TSX-V:MDX - TSX Venture Exchange - CA5850901037 - Common Stock - Currency: CAD
TSX-V:MDX (3/7/2025, 7:00:00 PM)
0.065
0 (0%)
The current stock price of MDX.CA is 0.065 CAD. In the past month the price decreased by -13.33%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
PRN.CA | PROFOUND MEDICAL CORP | N/A | 297.70M | ||
MIR.CA | MEDMIRA INC | N/A | 79.62M | ||
TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 61.95M | ||
PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 50.50M | ||
NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 33.97M | ||
CNVI.CA | CONAVI MEDICAL CORP | N/A | 28.76M | ||
VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 27.68M | ||
ASG.CA | AURORA SPINE CORP | N/A | 24.90M | ||
THRM.CA | THERMA BRIGHT INC | N/A | 15.91M | ||
EVMT.CA | EVOME MEDICAL TECHNOLOGIES I | N/A | 4.81M |
MedX Health Corp. engages in the development, manufacture, and sale of medical device and software. The company is headquartered in Mississauga, Ontario. The company went IPO on 2008-02-12. The company develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. The company focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use patented technology utilizing light and its remittance to view up to two millimeters beneath suspicious moles and lesions in a pain free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.
MEDX HEALTH CORP
1495 Bonhill Road, Unit # 1 Mississauga
Mississauga ONTARIO L5T 1M2 CA
CEO: Scott Spearn
Employees: 15
Company Website: https://medxhealth.com/
Investor Relations: http://medxhealth.com/investors
Phone: 18883633112
The current stock price of MDX.CA is 0.065 CAD.
The exchange symbol of MEDX HEALTH CORP is MDX and it is listed on the TSX Venture Exchange exchange.
MDX.CA stock is listed on the TSX Venture Exchange exchange.
MEDX HEALTH CORP (MDX.CA) has a market capitalization of 17.70M CAD. This makes MDX.CA a Nano Cap stock.
MEDX HEALTH CORP (MDX.CA) currently has 15 employees.
MEDX HEALTH CORP (MDX.CA) has a support level at 0.06 and a resistance level at 0.07. Check the full technical report for a detailed analysis of MDX.CA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
MDX.CA does not pay a dividend.
MEDX HEALTH CORP (MDX.CA) will report earnings on 2025-05-28.
MEDX HEALTH CORP (MDX.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.02).
Over the last trailing twelve months MDX.CA reported a non-GAAP Earnings per Share(EPS) of -0.02. The EPS increased by 39.72% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -447.65% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 84% to MDX.CA. The Buy consensus is the average rating of analysts ratings from 9 analysts.